Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer [Yahoo! Finance]
Hologic, Inc. (HOLX)
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.hologic.com
Company Research
Source: Yahoo! Finance
MENLO PARK, Calif. March 29, 2024 /PRNewswire/ -- Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc. , today announced the acquisition of Cirrus Bio for an undisclosed amount. Cirrus Bio develops and brings to market multiomic solutions for the diagnosis and management of diseases where early detection plays a critical role in clinical outcomes. The founders of Cirrus Bio, David Mallery (CEO) and Scott Morris (CSO), have previously founded and led the Molecular Profiling Institute (acquired by Caris Life Sciences), Paradigm Diagnostics (acquired by Exact Sciences), Viomics (acquired by Exact Sciences), and the International Genomics Consortium (non-profit supported by the National Cancer Institute). As part of the acquisition, Maverix also announced the formation of a dedicated diagnostic division called Maverix Dx that will develop, invest in, acquire, and bring to market a suite of diagnostic tools for lung cancer. David Mallery
Show less
Read more
Impact Snapshot
Event Time:
HOLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HOLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
News
- Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $91.00. They now have an "overweight" rating on the stock.MarketBeat
- Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up [Yahoo! Finance]Yahoo! Finance
- Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.MarketBeat
HOLX
Earnings
- 5/2/24 - Beat
HOLX
Sec Filings
- 5/3/24 - Form 8-K/A
- 5/3/24 - Form 10-Q
- 5/2/24 - Form 8-K
- HOLX's page on the SEC website